Asiri Hospital Holdings PLC (ASIR.N0000) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Asiri Hospital Holdings PLC has changed its score on 03 Dec 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Operating profit has grown by an annual rate 20.80% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Capital Employed (avg) of 14.52% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Operating profit has grown by an annual rate 20.80% of over the last 5 years

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

LKR 35,491 Million (Large Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.84

Return on Equity

18.05%

Price to Book

1.62

Revenue and Profits:

Net Sales:

8,720 Million

(Quarterly Results - Jun 2025)

Net Profit:

1,226 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-21.05%

6 Months

17.19%

1 Year

20.0%

2 Years

22.95%

3 Years

12.78%

4 Years

-8.26%

5 Years

13.64%

Asiri Hospital Holdings PLC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

16.79%

EBIT Growth (5y)

20.80%

EBIT to Interest (avg)

2.33

Debt to EBITDA (avg)

2.69

Net Debt to Equity (avg)

0.83

Sales to Capital Employed (avg)

0.75

Tax Ratio

37.64%

Dividend Payout Ratio

103.81%

Pledged Shares

Institutional Holding

ROCE (avg)

14.52%

ROE (avg)

15.89%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.56

EV to EBIT

8.94

EV to EBITDA

7.19

EV to Capital Employed

1.32

EV to Sales

1.71

PEG Ratio

2.85

Dividend Yield

ROCE (Latest)

14.78%

ROE (Latest)

13.94%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.95% vs 5.93% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.96% vs 123.54% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,720.30",
          "val2": "8,230.20",
          "chgp": "5.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,471.50",
          "val2": "1,815.20",
          "chgp": "36.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "492.60",
          "val2": "545.60",
          "chgp": "-9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,226.30",
          "val2": "1,125.50",
          "chgp": "8.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "224.70%",
          "val2": "220.50%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.54% vs 15.27% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -9.15% vs 83.54% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31,010.20",
          "val2": "28,571.50",
          "chgp": "8.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,368.50",
          "val2": "7,992.50",
          "chgp": "-7.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,039.90",
          "val2": "3,585.20",
          "chgp": "-43.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,833.40",
          "val2": "3,118.90",
          "chgp": "-9.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.00%",
          "val2": "212.50%",
          "chgp": "-3.85%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

8,720.30

8,230.20

5.95%

Operating Profit (PBDIT) excl Other Income

2,471.50

1,815.20

36.16%

Interest

492.60

545.60

-9.71%

Exceptional Items

0.00

Consolidate Net Profit

1,226.30

1,125.50

8.96%

Operating Profit Margin (Excl OI)

224.70%

220.50%

0.42%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.95% vs 5.93% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 8.96% vs 123.54% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

31,010.20

28,571.50

8.54%

Operating Profit (PBDIT) excl Other Income

7,368.50

7,992.50

-7.81%

Interest

2,039.90

3,585.20

-43.10%

Exceptional Items

0.00

Consolidate Net Profit

2,833.40

3,118.90

-9.15%

Operating Profit Margin (Excl OI)

174.00%

212.50%

-3.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 8.54% vs 15.27% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -9.15% vs 83.54% in Mar 2024

All Annual Results

Company CV

About Asiri Hospital Holdings PLC

Asiri Hospital Holdings PLC

Hospital

Asiri Hospital Holdings PLC is engaged in providing healthcare and hospital services. The Company operates a hospital, provides healthcare services, and manages and holds investments in the healthcare industry. The Company provides its tests in various areas, such as chemical pathology, biochemistry, clinical pathology, hematology, microbiology, histology and immunology. The Company offers various services, which include critical care wards, neonatal intensive care unit, dialysis unit, operating theaters, intensive care unit, e-channeling consultation, emergency medical service unit, ultrasound scanning, echocardiography with two dimension (2D) Doppler analysis, pharmacy, mobile electrocardiogram, mobile laboratory service, X-ray with image intensifying and screening facilities, stress echocardiography and periodic medical check-up scheme. Its subsidiaries include Asiri Central Hospitals Ltd., Asiri Hospital Matara (Pvt) Ltd and Hemas Southern Hospitals (Private) Limited.

Company Coordinates

Company Details

181, Kirula Road, Colombo 5 , COLOMBO None : 05

Tel: 94 11 4523300

http://www.asirihealth.com/asiri-group/group-overview/financial-information

Registrar Details